NEW YORK, June 18 - AlphaGene has partnered with Indian bioinformatics company Questar to mine its protein database, the companies said Monday.
In the collaboration, Questar, of Ameerpet, Hyderabad will make an equity investment in Woburn, Mass.-based AlphaGene.
Financial terms of the deal were not disclosed.
Questar will provide bioinformatics to aid AlphaGene in determining protein structure, pathway identification and creation of a library of potential small molecule ligands for selected putative proteins, the company said. Questar will also build standardization across AlphaGene databases.
"In completing this collaboration, Questar has signaled its desire to build intellectual property in downstream therapeutic projects with significant market potential," C.S.N. Murthy, CEO of Questar, said in a statement. "We are delighted to have the opportunity to collaborate with AlphaGene and thereby create a platform for our activities in the United States."
AlphaGene is a privately held genomics that focuses on differential gene expression in degenerative neurological diseases such as Parkinson's and Alzheimer's.
Questar uses bioinformatics to carry out molecular-based research into diabetes, cancer, neurological disorders, and cardiovascular diseases.